Related Experiment Video

Updated: Aug 30, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

[Influenza pneumonia]

Valérie Zeller1, François Bricaire

  • 1Service des maladies infectieuses et tropicales, groupe hospitalier de La Pitié-La Salpêtrière, 75651 Paris. valerie.zeller@psl.ap-hop-paris.fr

La Revue Du Praticien
|October 16, 2003
PubMed

Insights

Influenza can cause primary viral pneumonia with high mortality or secondary bacterial pneumonia, often in the elderly. Bacterial pneumonia typically resolves with antibiotics, but outcomes depend on patient health.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Critical Care Medicine

Context:

  • Influenza virus infections can lead to severe respiratory complications.
  • Pneumonia represents a significant cause of morbidity and mortality associated with influenza.

Purpose:

  • To differentiate between primary viral and secondary bacterial pneumonia following influenza.
  • To outline the clinical presentation, common pathogens, and outcomes for each pneumonia type.

Summary:

  • Primary viral pneumonia presents with rapid dyspnea post-influenza, potentially leading to acute respiratory distress syndrome (ARDS), with high mortality despite respiratory support.
  • Secondary bacterial pneumonia, more common in the elderly or those with chronic lung disease, involves bacterial pathogens like Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.
  • This type often follows an initial influenza recovery, characterized by pulmonary consolidation and generally favorable outcomes with antibiotic treatment, contingent on the patient's baseline health.

Impact:

  • Understanding these distinctions is crucial for timely and appropriate clinical management of influenza-associated respiratory illnesses.
  • Highlights the importance of considering secondary bacterial infections in influenza patients, especially vulnerable populations.
  • Informs treatment strategies and prognosis assessment for patients with influenza-related pneumonia.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy08:01

Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy

Published on: August 17, 2018

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: